MedLink Neurology is an interactive service for up-to-date information on clinical neurology. MedLink Neurology provides immediate access to an exclusive collection of more than 1000 in-depth, yet concise, clinical summaries on neurologic disorders and related topics. Written and kept up-to-date by experts, the clinical summaries contain links to thousands of abstracts and hundreds of informative videos and other illustrations in the MedLink library.

Epilepsy and Pregnancy

The most common, understandable question for any mother-to-be, whether suffering from epilepsy or not, is "will my baby be normal"? It is important at the outset to reassure the reader that more than 95% of all babies born to mothers with epilepsy are healthy and normal.

But for women with epilepsy there are several additional questions:
(1) Will the epilepsy or the medications I take make it harder to conceive?
(2) Once I am pregnant, what will happen with regard to my seizures?
(3) Once I am pregnant, what will anticonvulsant drugs do to the fetus?

Epilepsy, antiepileptic drugs, and fertility
There are some confusing and conflicting issues with respect to women who have epilepsy and their ability to become pregnant; relatively speaking, a woman with epilepsy has about a 1 in 3 chance of getting pregnant compared to a woman who does not suffer epileptic seizures. On the other hand, the antiepileptic drugs (AEDs) used to treat epileptic seizures may interfere with the oral contraceptive pill and lead to a very slight risk of "contraceptive failure." Therefore, it is advised that women taking oral contraceptive pills for fertility control also take additional precautions.

Epilepsy, anticonvulsant drugs, and pregnancy
Despite the suggestion above that some women with epilepsy may find it hard to become pregnant, the majority of women with epilepsy, when they decide to have a baby, conceive relatively easily and will deliver a normal, healthy baby.

Once pregnant, what happens to the seizures?
As a rule of thumb, during the 9 months of a pregnancy:

-- Between 15% to 30% of women will experience an increase in seizures
-- A small percentage of women may note an improvement in seizure control
-- The majority (50% to 70%) will experience no change in seizure activity

There is some evidence that suggests if the epilepsy is under excellent control before pregnancy, then seizures will remain well controlled during pregnancy. Conversely, seizures that are frequent and difficult to control before conception are likely to be just as difficult to control and even more frequent during pregnancy.

There is no single reason for an exacerbation of seizures during pregnancy, it is probably a combination of lower drug levels in the body as weight increases, hormonal changes, and even perhaps the psychological stresses of pregnancy, including the understandable anxiety and apprehension of not knowing the ultimate pregnancy outcome. Occasionally a woman may decide on her own to stop anticonvulsant drugs because of fears they may "harm the baby." Although this is understandable it sadly may lead to a worse outcome than continuing medication. It is very important that women with epilepsy be open and frank with their neurologist and obstetrician and discuss any fears and anxieties they have, and that they DO NOT stop taking prescribed medication suddenly without telling their doctor(s).

Type of seizure may be an important factor in discussing risks during pregnancy. A generalized tonic clonic seizure (grand-mal) may be potentially more catastrophic to mother, fetus, or both, than a partial seizure where there is just a transient loss of awareness, often without a fall.

Anticonvulsants and teratogenesis (fetal malformations)
Women with epilepsy, have a slightly increased risk of fetal malformation. There are 2 possible reasons:

-- A grand mal seizure (generalized tonic/clonic) is often so convulsive that it may: rarely induce a miscarriage, or injure the fetus in the womb, or briefly reduce the supply of blood (and therefore nutrition and oxygen ) to the fetus, and may even cause trauma to the mother.

-- Anticonvulsants may affect the developing embryo, mainly in the first 6 weeks of pregnancy, as the baby's tiny organs, including the brain and spinal cord, are forming.

In the past it was hard to provide women with good scientific information on the risks associated with antiepileptic drugs and pregnancy, as reports of babies being born with malformations are very rare. This lack of good and reputable data led a few years ago to an international "Pregnancy Register" that includes data from Europe, North America, and Australia. The information is shared and combined; consequently, the true risks of a baby being born with malformations to a mother taking antiepileptic drugs can now be discussed with some confidence. The Australian Pregnancy Register has statistics up until May 2003, so it is current and provides a scientific basis for professional advice.

It is important that all women with epilepsy are familiar with the risks of fetal malformations in the "normal" female population. In other words, what is the risk of a healthy woman without epilepsy and not taking drugs having a baby born with a malformation? The answer is between 2% to 3% (or 2 or 3 out of every 100 normal births).

The reassuring statistics are that for every 100 women with epilepsy who are taking antiepileptic drugs and who have a successful full-term baby, about 88 (88%) have an absolutely normal baby. The remaining 12 women will have complications, of which, 6 (6%) will have a baby with a fetal malformation. Although this calculates out to a rate that is double the normal rate of complications, it must be remembered that this is still a small absolute number and risk.

The other 6 women will experience either spontaneous abortions or death of the baby in utero. However, these latter rare and catastrophic complications occur in women without epilepsy and not taking antiepileptic drugs at about this rate.

There is increasing evidence from these statistics, that of all antiepileptic drugs, valproate (Epilim, Valpro) has a slightly greater risk of causing potential malformations. However, this increased risk was only seen in patients taking high doses, of the order of 2000 mg per day (4 tablets at 500 mg strength). At a dose of 1000 mg, the risk was much lower. This isolated finding needs to be considered on an individual basis, as it's possible that not taking valproate may be associated with a greater risk of damage to the baby due to uncontrolled seizures.

Current recommendations
Current recommendations in women who suffer generalized tonic clonic seizures (grand mal) are:

(1) that all women of child bearing age who are capable of conceiving take folic acid supplements together with their antiepileptic drugs. How much folic acid remains open to argument, but there have been scientific trials in which dosages from 0.8 milligram per day to 5 milligram per day have been used successfully. The current recommendation by the Center for Disease Control is that all women of childbearing age should supplement with 0.4 milligrams per day of folic acid.
(2) that pregnancy should be planned so that the treating neurologist and female patient may discuss possible anticonvulsant combinations
(3) that the ideal situation is to use 1 drug rather than multiple drugs and at the lowest possible dosage to control seizures, (recognizing that in some women 2 or more drugs may be necessary to control potentially damaging seizures).

Finally, a word of reassurance: the risk of damage to the developing fetus because of either seizures or the use of antiepileptic drugs is minimal. Current evidence suggests about 90% of women with epilepsy will have a normal, healthy baby.

This information was written by Graham Norton FRACP, and is herewith used with permission. It was last updated May 8, 2004.

The information in this document is for general educational purposes only. It is not intended to substitute for personalized professional advice. Although the information was obtained from sources believed to be reliable, MedLink Corporation, its representatives, and the providers of the information do not guarantee its accuracy and disclaim responsibility for adverse consequences resulting from its use. For further information, consult a physician and the organization referred to herein.

Copyrightę MedLink Corporation 1993-2005 All Rights Reserved

This site is developped by Massoud Bina, M.D. and Morteza Bina, Ph.D. All rights reserved. Copyright ©2005. Site Administrator: morteza@massoudbina.com